Provided By PR Newswire
Last update: Jan 23, 2025
Panel expansion planned over the next three years to cover the majority of canine cancer cases, transforming cancer detection and supporting earlier intervention
Read more at prnewswire.comNASDAQ:IDXX (6/4/2025, 1:19:22 PM)
527.91
+2.08 (+0.4%)
Find more stocks in the Stock Screener
IDEXX Laboratories (IDXX) is a high-quality stock with strong revenue growth, exceptional profitability, and solid financial health, making it a compelling pick for long-term investors.